Metraipolis › archive › dc_50deb4af1bfd

Risk of Parkinson's disease in patients with schizophrenia: Impact of antipsychotic medication use — Europe PMC PMID:42081568

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42081568
DOI
10.1371/journal.pone.0346233
License (as archived)
solo-consultazione
Archived
2026-11-02T17:51:01.447Z
SHA-256 of the archived text
b9f89c6877d2866969bba6b3f5fb61fceb1573ae9c1f1bfcd45e4cda9691461f
Stable URL of this page
https://metraipolis.com/documento/dc_50deb4af1bfd

How to cite

Risk of Parkinson's disease in patients with schizophrenia: Impact of antipsychotic medication use — Europe PMC PMID:42081568 — Europe PMC (en), https://europepmc.org/article/MED/42081568 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50deb4af1bfd (Metraipolis archive dc_50deb4af1bfd, sha256 b9f89c6877d2866969bba6b3f5fb61fceb1573ae9c1f1bfcd45e4cda9691461f)
BibTeX
@misc{dc50deb4af1bfd,
  title = {Risk of Parkinson's disease in patients with schizophrenia: Impact of antipsychotic medication use — Europe PMC PMID:42081568},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42081568},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50deb4af1bfd; sha256 b9f89c6877d2866969bba6b3f5fb61fceb1573ae9c1f1bfcd45e4cda9691461f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42081568. Agents can read the archived copy with the MCP tool read_document.